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Abstract
Background: The weighted estimators generally used for analyzing case-cohort studies are not fully efficient and
naive estimates of the predictive ability of a model from case-cohort data depend on the subcohort size. However,
case-cohort studies represent a special type of incomplete data, and methods for analyzing incomplete data
should be appropriate, in particular multiple imputation (MI).
Methods: We performed simulations to validate the MI approach for estimating hazard ratios and the predictive
ability of a model or of an additional variable in case-cohort surveys. As an illustration, we analyzed a case-cohort
survey from the Three-City study to estimate the predictive ability of D-dimer plasma concentration on coronary
heart disease (CHD) and on vascular dementia (VaD) risks.
Results: When the imputation model of the phase-2 variable was correctly specified, MI estimates of hazard ratios
and predictive abilities were similar to those obtained with full data. When the imputation model was misspecified,
MI could provide biased estimates of hazard ratios and predictive abilities. In the Three-City case-cohort study,
elevated D-dimer levels increased the risk of VaD (hazard ratio for two consecutive tertiles = 1.69, 95%CI: 1.63-1.74).
However, D-dimer levels did not improve the predictive ability of the model.
Conclusions: MI is a simple approach for analyzing case-cohort data and provides an easy evaluation of the
predictive ability of a model or of an additional variable.
Background
Case-cohort surveys produce incomplete data by design.
A subcohort is selected by simple or stratified random
sampling, all subjects are followed up and the events of
interest are recorded. The phase-1 variables are
observed for the entire cohort, whilethe phase-2 vari-
ables are only known for the case-cohort sample, i.e.,
subjects belonging to the subcohort and all those pre-
senting the event of interest [1]. Thus, in case-cohort
studies, the non-cases who do not belong to the subco-
hort are incompletely observed by design, enabling cost
reduction with a small loss of efficiency.
Various approaches have been described to estimate
the proportional hazard model in case-cohort surveys:
Weighted estimators [2-6] are classically used in these
surveys, with analysis restricted to the completely
observed subsample, so the information collected for
incompletely observed non-cases is ignored and ineffi-
cient estimators for the effect of phase-1 variables are
obtained. One of the most popular is the Borgan II esti-
mator [4]. Scheike and Martinussen [7] proposed a max-
imum likelihood estimator based on proportional
hazards assumption, using the EM algorithm [8], there-
byincreasing efficiency as compared to weighted estima-
tors when the relative risk and disease incidence are
high. However, in general, the studied disease incidence
in case-cohort surveys is low. Breslow et al. [9] sug-
gested calibrating or estimating the weights a posteriori,
using all the phase-1 information, to improve precision
with respect to classical weighted estimators. Marti and
Chavance [10] showed that multiple imputation (MI) is
a good alternative to classical weighted methods for the
analysis of case-cohort data. When the imputation
model was correct, the MI approach provided unbiased
estimators of the log hazard ratios and correctly esti-
mated the variance of its estimators. As expected, the
MI approach was more precise than the usual weighted
estimators for the parameters associated with phase-1
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any medium, provided the original work is properly cited.variables. The former was also slightly more precise than
the latter for the phase-2 variable. In Marti and Cha-
vance [10] the imputations were performed according to
a correctly specified imputation model. However, in
practise, the distribution of the phase-2 variable is
unknown and onemay wonder how MI compares to
weighted estimators when the imputation model is
misspecified.
No standard method exists for quantifying the useful-
ness or predictive ability of a model or an additional
variable in the framework of case-cohort surveys. The
predictive ability can be measured in terms of calibra-
tion, which refers to the ability of a model to match pre-
dicted and observed values, when we are interested in
individual predictions; or in terms of discrimination,
which refers to the ability of a model to distinguish
between subjects with or without a binary event, when
we are interested in identifying a group of high-risk sub-
jects. In the present work, we focus on discrimination.
As shown below, a naive measurement of predictive
ability from case-cohort data often leads to a biased esti-
mate of the predictive ability because it varies with the
censoring rate and thus depends on the subcohort size.
Alternatively, because MI reconstitutes whole cohorts,
any tool developed to estimate the predictive ability in
the framework of cohort surveys can be applied to case-
cohort data, so we propose using the MI approach to
estimate the predictive ability ofa model or of an addi-
tional variable and their standard errors.
The objectives of this study were 1) to evaluate MI for
estimating hazard ratios when the distribution of the
phase-2 variable is misspecified; and 2) to present an
adequate methodology for estimating the predictive abil-
ity of a model or of an additional variable in case-cohort
surveys. We performed a simulation study to validate
the MI approach for estimating the predictive ability of
a model or of an additional variable and to assess its
potential limits. As an illustration, we analyzed case-
cohort data from the Three-City study [11] to estimate
the predictive ability of the D-dimer plasma concentra-
tion, a marker of coagulation and fibrinolysis, on coron-
ary heart disease (CHD) and on vascular dementia
(VaD) risks.
Methods
Incomplete observations and multiple imputation
Case-cohort surveys are a particular type of incomplete
observations, in which data are missing at random [12]
by design, as the probability of being completely
observed depends only on the case status, with simple
random sampling, and on some phase-1 variables with
stratified sampling. MI is a simple and efficient method
for analyzing incomplete observations, while taking into
account all the levels of uncertainty regarding missing
values. This provides an approximation of the maxi-
mumlikelihood estimator and thus enables the potential
selection bias to be corrected. This method relies on the
generation of several plausibly completed data sets (M ≥
2), accounting for all levels of uncertainty concerning
the missing values. A prediction model must be built,
taking into consideration the relationships between the
incomplete variable and the other variables, as observed
in the complete part of the data. The missing data are
not replaced by their expectation but by a value drawn-
from the distribution posited by the model. To take into
account the uncertainty concerning the parameters of
the imputation model, several imputations are per-
formed with parameters drawn from the asymptotic dis-
tribution of their estimator. An estimate of the
parameter of interest, ˆ θm,m = {1,...,M}, and an esti-
mate of the variance of the estimator, ˆ V(ˆ θm), are
obtained from each completed data set. If the imputa-
tion model is correct, these estimators are not biased.
The MI estimate, also unbiased, is the mean of the M
estimates:
ˆ θMI =
1
M
M 
m=1
ˆ θm (1)
where M is the number of completed data sets and
ˆ θm,m = { 1,...,M} is the estimate of the parameter of
interest provided by the m
th completed data set. The
multiplicity of imputations enables correct estimation of
the variance of this single estimator, which is the sum of
2 components: the within-imputations component, WMI,
and the between-imputations component, BMI:
ˆ V(ˆ θMI)= ˆ WMI + ˆ BMI
=
1
M
M 
m=1
ˆ V(ˆ θm)+( 1+M−1)
M
m=1 (ˆ θm − ˆ θMI)(ˆ θm − ˆ θMI) 
M − 1
(2)
where the factor 1 + M
-1 is an adjustment for using a
finite number of imputations [13].
MI requires a model correctly reflecting the relation-
ship between the incomplete variable and the outcome
of interest. In case-cohort surveys, we need to impute
phase-2 variable values for the non-cases who do not
belong to the subcohort. Under the rare disease assump-
tion, we have shown that a simple generalized linear
model, using all the complete data (cases and non-cases)
and including the case indicator among the explanatory
variables, has to be considered [10]. Practically, in addi-
tion to the case indicator and the stratification variables,
when the subcohort was selected by stratified sampling,
it is necessary to include in the imputation model all
the variables appearing in the proportional hazard
model. Because imputations are based on asymptotic
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jects present the event of interest, the distribution of the
estimators can differ from the asymptotic one. As a con-
sequence, the maximum likelihood estimator of the
imputation model could be biased or not normally
distributed.
Predictive ability of a model and of a supplementary
variable
Harrell et al. [14] proposed the C index to measure the
predictive ability of a model in cohort studies as the
agreement between the order of the predicted and
observed survival times in any pair of subjects (the
event of interest is assumed to be death, leading to the
use of survival terminology). That is, the concordance
probability using all pairs of subjects in the population.
However, with censored data, it is not possible to con-
sider all the pairs of subjects because survival time is
not observed for censored subjects. Let Ti be the survi-
val time for subject i, i = 1,...,N,w h e r eN is the cohort
size, and Ci the censoring time for subject i. We observe
Xi = min(Ti, Ci). Usable pairs are those for which the
order of the predicted survival times can be compared
to the order of the true survival times, i.e., pairs formed
by 2 uncensored subjects or an uncensored subject and
a subject censored after the uncensored subject’s death.
A pair of censored subjects carries no information about
its agreement with the expected survival provided by the
model since the order of the survival times is not
known. Similarly a pair formed by a subject whose sur-
vival time is observed and a subject censored before this
survival time provides no information on this agreement
since the unknown survival time could be anterior or
posterior to the observed one. Harrell et al. [15] showed
that, in the common models used for survival analysis,
such as the proportional hazard model, the predicted
survival times and the predicted survival probabilities at
af i x e dt i m et can be interchanged for the comparison.
The Harrell’s C index is defined as:
C =
πc
πc + πd
(3)
where πc is the probability of concordance for a pair
(i,j) and πd is the probability of discordance. We assume
continuous survival times and continuous predicted sur-
vival probabilities, so P(Xi = Xj)=P(Yi = Yj) = 0, thus πc
+ πd =1 .C is estimated by the proportion of concor-
dant pairs among the usable pairs. The estimated var-
iance was given by Kremers [16].
In practice, we are often interested in estimating the
predictive ability of an additional phase-2 variable. Let
M1 be a proportional hazard model including only
phase-1 variables, and C1 and SEC1 respectively the C
indexof M1 and its standard error. Let M2 be a propor-
tional hazard model adding the phase-2 variable to M1,
and C2 and SEC2, respectively, the C index of M2 and its
standard error. Harrell’s predictive ability ofthe added
phase-2 variable is Δ = C2 - C1 . Complementary mea-
sures of predictive ability of a new variable, such as the
net reclassification improvement (NRI) and the inte-
grated discrimination index (IDI), were proposed by
Pencina [17]. NRI needs some a priori meaningful risk
categories. It quantifies the correct reclassification intro-
duced by using a model with the added variable as com-
pared to the classification obtained without this variable.
The IDI can be viewed as a continuous version of the
NRI with probabilities used instead of categories. It can
be defined as the discrimination-slope difference
between the models with and without a quantitative
variable. To estimate the predictive ability of a model or
of an additional variable, we reconstructed plausible
whole cohorts using MI. For each reconstructed whole
cohort, we could then directly obtain C1, SEC1, C2, SEC2,
Δ, NRI, IDI and their respective variances. Using equa-
tions (1) and (2), we obtained the MI estimates of these
quantities. Concerning the variance of Δ, the between-
imputation component is estimated by the empirical
variance of the M estimates of Δ provided by the M
completed data sets. However, for the within-imputation
component, the asymptotic variance of the estimator
provided by a complete data set, does not have an analy-
tical form. With a fully observed cohort, bootstrapping
is a way to estimate the variance of the corresponding
Δ.T h e r e f o r e ,e a c hw h o l ec o h o r tr e c o n s t r u c t e db yM I
has to be resampled. In the simulations as in the real
data analysis, we used 100 bootstrap samples.
Simulation study
Two phase-1 variables were simulated: a binary variable,
Z1, and a Gaussian variable, Z3, observed for the entire
cohort. For the phase-2 variable, Z2,w ec o n s i d e r e d
three different distributions: normal, log-normal and
uniform, all of them with unit variance, independent of
Z1, but having a correlation coefficient of 0.2 with Z3.
The survival time had an exponential distribution, with
l = exp (b1Z1 + b2Z2 + b3Z3 ). b1, b2 and b3 were fixed
at the same value and set at 0 or log(2). The censoring
time followed a uniform distribution over the interval
[0,τ], where τ was chosen so that the probability of an
event was approximately 0.03 (τ= 0.025). The cohort
size was 10,000. We also simulated a phase-1 variable
predictive of Z2, ˜ Z2 ≡ Z2 + εwith ε ~N(0, s
2) indepen-
dent of Z2.T h ev a r i a n c es
2 was fixed at 1 which corre-
sponds to a correlation between Z2 and ˜ Z2 of
approximately 0.7. We wanted to estimate the effect of
Z2 on survival time and its predictive ability. The cohort
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˜ Z2 andZ3, and the non-cases were chosen by stratified
sampling. Case-cohort sampling was simulated with
1,000 subjects in each subcohort. The phase-2 variable
was not available for non-cases not included in the sub-
cohort, so MI was used to complete the data set. Thus,
we built the same linear prediction model for each Z2
based on the stratification phase-1 variable and the case
indicator. Z3 was not directly included in the imputation
model to predict Z2, because it was a stratification vari-
able included in the model and because of the weak cor-
relation between Z2 and Z3. The imputation model was:
Z2 = a0 + a1 Icase + a2 Strata + ε , where a0 and a1 are
scalar, a2 is a vector coefficient, Icase is the case indica-
tor, Strata is the vector of stratum indicators and є is
the vector of errors independently and identically dis-
tributed ~ N (0, s). Thus, the imputation model was
correctly specified for Z2 normally distributed but mis-
specified for Z2 log-normally or uniformly distributed.
One thousand cohorts were simulated for each scenario.
Five imputations were performed and 5 complete data
sets were generated for each cohort. We estimated the
log hazard ratios using MI and the “Borgan II” weighted
estimator [4]. We used MI to estimate the predictive
ability of models with and without the phase-2 variable,
and the predictive ability of the phase-2 variable, NRI
and IDI. We also studied the consistency of the naive
estimator of Harrell’s C index in case-cohort surveys by
varying the subcohort size. Using the above simulation
conditions and, exceptionally, a scenario with b1 = b3 =
log(2) and b2 = log(1.5), we simulated case-cohort sam-
ples with the subcohort size set at 300 or 1,000 subjects.
We estimated the predictive ability in the case-cohort
samples and in the multiply imputed data sets.
Case-cohort survey from Three-City study
Briefly, the 3C-Study was designed to examine the rela-
tionship between vascular diseases and dementia in a
community housing 9,294 persons aged 65 years and
over between 1999 and 2001 in three French cities. The
detailed methodology has been previously described [11].
A case-cohort substudy was conducted [18], to investi-
gate the relationship between biomarkers, such as plasma
levels of D-dimer (a marker of coagulation and fibrinoly-
sis) and the 4-year incidence of coronary heart disease
(CHD), stroke and all subtypes of dementia, including
vascular dementia (VaD), in an elderly population. The
phase-1 variables provided information on socio-demo-
graphic characteristics, education, medical history, diet,
alcohol and tobacco use. Blood pressure, height and
weight were also available. A subcohort of size n = 1,254,
(13.5% of the full cohort) was randomly selected, stratify-
ing on age, sex and recruitment center. Observed
cumulated incidences of CHD and VaD were approxi-
mately 2% and 0.6%, respectively. Plasma D-dimer levels
were only available for phase-2 subjects. Carcaillon et al.
[18] treated quintiles of D-dimer level both qualitatively
and linearly. They reported a linear increase in the risk of
VaD according to D-dimer quintiles.
We re-assessed the relationship between plasma D-
dimer levels and the risk of CHD and VaD, using MI and
weighted estimators, and evaluated the predictive ability of
D-dimer levels on both risks. We included the same expla-
natory variables as Carcaillon et al. [18] although we used
tertiles of D-dimer rather than quintiles, to estimate CHD
and VaD risks, due to the small number of events. There-
fore, to estimate the risk of CHD, the proportional hazard
model includedthe phase-1 variables: age, sex, center, body
mass index, hypertension, hypercholesterolemia, diabetes,
tobacco use, diabetes drugs, and as phase-2 variables, indi-
cators of D-dimer tertiles. To estimate the risk of VaD, the
proportional hazard model included the phase-1 variables:
age, sex, centre, educational level, body mass index, the
presence or absence of an apolipoprotein є4a l l e l ea n d
indicators of D-dimer tertiles.
For each outcome (CHD or VaD), it was necessary to
reproduce the relationships among the incomplete vari-
able, the outcomes and the confounder variables. For
each outcome, we built an imputation model of tertiles
of D-dimer levels, including the variables used in the
proportional hazard model and the case-indicator. We
estimated the predictive ability of proportional hazard
models, without (C1)a n dw i t h( C2) D-dimer levels, Δ =
C2-C1, and IDI for CHD and VaD risks. The NRI
requires that some a priori meaningful risk categories be
known. Based on the Third Adult Treatment Panel
[ATP III] [19] risk classification for the 10-year risk of
CHD, we adapted the cut-offs to 4-year risk. For VaD,
we do not know a priori meaningful risk categories and
did not compute NRI.
Results
Simulation study
The mean fraction of missing information about the
effect of Z2 ranged from 5 to 14 percent when b2 =0
and from 23 to 30 per cent when b2 = log(2) (data not
shown). For each estimator (full cohort, case-cohort
with MI and case-cohort with weights), we give the
mean of the estimated coefficients, the mean of their
standard error estimates, the observed standard error of
the estimated coefficients and the mean squared errors
of 1000 simulations (Table 1). Not surprisingly, the full
cohort estimates and the case-cohort weighted estimates
of the log hazard ratios were unbiased. Similarly, with a
correctly specified normal imputation model, all MI esti-
mates were unbiased. With a misspecified normal
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of Z2 was biased (-13%) when Z2 was log-normally dis-
tributed. When Z2 was uniformly distributed, MI esti-
mate of the effect of Z2 was slightly biased (-5%). With
a misspecified normal imputation model and b2=0 ,n o
bias was observed. TheMI variance and the weighted
estimator variance agreed with the observed dispersions
of the estimates. The observed dispersion was always
smaller with MI than with the weighted estimator. For
the phase-1 variables, this dispersion was similar for the
entire cohort and with MI, whatever the distribution of
the phase-2 variable. For the estimated effect of the
phase-2 variable, the observed standard deviations were
smaller with MI than with the Borgan II weighted esti-
mator but, as expected, slightly larger with MI than in
the full cohort analyses. Altogether, the mean squared
errors were smaller with MI than with the weighted
estimator, except for the effect of the phase-2 variable
with b2 = log(2) and Z2 was log-normally distributed.
The results concerning the consistency of the naive
estimator of Harrell’s C index are reported in Table 2.
In the scenario b1 = b 2 = b3 = 0, the mean C index was
nearly 0.5 for both models, without and with Z2,w h a t -
ever the analysis performed. In the scenarios b1 = b3 =
log(2) and b2 = log(1.5) or b2 = log(2), the naive compu-
tation of C with the case-cohort data led to lower pre-
dictive ability than with the full cohort, especially for
the smaller subcohort. Bycontrast, the Harrell’s C
indexes estimated by MI were similar to those com-
puted for the full cohort and did not depend on the
subcohort size. The estimated dispersion of the C index
was slightly greater than the observed dispersion of the
estimates. The rejection percentage of the null hypoth-
esis Δ = 0 was always similar to the full cohort analysis
and to MI. As a consequence of the standard error over-
estimation, the observed first type error rate was slightly
lower than 5%. Nevertheless, in the considered scenar-
ios, the observed power was very high. As expected, the
Table 1 Mean of the log hazard ratio estimates (Est), mean of the standard error estimates
∧
SE , standard error of the
estimates (SE) and mean of the mean square error (MSE). Results of 1,000 simulations.
Full cohort Multiple imputation
a Weighted estimator
Est
∧
SE SE MSE Est
∧
SE SE MSE Est
∧
SE SE MSE
Z2 normally distributed
b1 = b2 = b3 =0
b1 -0.003 0.107 0.100 0.010 -0.003 0.107 0.110 0.010 -0.001 0.133 0.128 0.016
b2 -0.001 0.054 0.058 0.003 -0.001 0.060 0.062 0.004 0.001 0.065 0.068 0.005
b3 -0.004 0.053 0.056 0.003 -0.004 0.054 0.057 0.003 -0.003 0.058 0.060 0.004
b1 = b2 = b3 = log(2)
b1 0.689 0.118 0.113 0.013 0.676 0.119 0.112 0.013 0.696 0.168 0.165 0.027
b2 0.687 0.058 0.057 0.003 0.679 0.070 0.068 0.005 0.701 0.088 0.097 0.009
b3 0.683 0.057 0.057 0.003 0.679 0.058 0.058 0.004 0.689 0.080 0.090 0.007
Z2 log normally distributed
b1 = b2 = b3 =0
b1 -0.003 0.107 0.100 0.010 -0.003 0.107 0.100 0.010 -0.004 0.133 0.128 0.016
b2 -0.001 0.027 0.034 0.001 0.015 0.031 0.032 0.001 0.002 0.034 0.038 0.001
b3 -0.004 0.053 0.056 0.003 -0.004 0.054 0.058 0.004 -0.005 0.059 0.062 0.004
b1 = b2 = b3 = log(2)
b1 0.686 0.058 0.056 0.003 0.621 0.061 0.055 0.008 0.686 0.112 0.117 0.014
b2 0.692 0.013 0.015 2e0
-4 0.602 0.015 0.014 0.008 0.695 0.020 0.023 0.001
b3 0.685 0.029 0.031 0.001 0.686 0.032 0.031 0.001 0.687 0.049 0.053 0.003
Z2 uniformly distributed
b1 = b2 = b3 =0
b1 0.007 0.181 0.175 0.031 0.007 0.181 0.175 0.031 0.007 0.197 0.188 0.035
b2 -0.001 0.092 0.087 0.008 0.004 0.094 0.088 0.008 -0.002 0.098 0.095 0.009
b3 0.003 0.090 0.090 0.008 0.002 0.090 0.090 0.008 0.004 0.093 0.093 0.009
b1 = b2 = b3 = log(2)
b1 0.690 0.120 0.116 0.013 0.680 0.121 0.115 0.013 0.694 0.166 0.169 0.028
b2 0.695 0.069 0.063 0.004 0.656 0.075 0.066 0.006 0.698 0.087 0.082 0.007
b3 0.690 0.058 0.054 0.003 0.689 0.059 0.055 0.003 0.698 0.081 0.081 0.007
a MI estimates with imputation model: Z2 = a0 + a1Indcase + a2Strata + ε, ε ~ N(0, s)
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full cohort analysis was small: with b2 = log(1.5), the
observed power was 84.6% with a subsample size of 300,
and 90.6% with a subsample size of 1000 versus 91.6%
with the full cohort. MI estimates of NRI and IDI
indexes were close to those obtained with the full cohort
analysis and did not depend on the subcohort size. As
compared to the full cohort results, the rejection per-
centage of the null hypothesis NRI = 0 was smaller with
MI analysis when b2 =0 ,l a r g e rw h e nb2 = log(1.5) and
similar when b2 = log(2). When the effect of the phase-2
variable was not null, the rejection percentage of the
null hypothesis IDI = 0 was similar with MI and with
full cohort analysis. By contrast, whatever the effect of
the phase-2 variable, the estimation of NRI and IDI in
the case-cohort sample provided larger measures of
these indexes than the full cohort analysis.
Table 3 gives the results of the estimated predictive
abilities for the correctly specified and the two misspeci-
fied normal imputation models. Full cohort analysis and
MI provided similar predictive abilities estimates when
the imputation model was correctly specified or when
the phase-2 variable had no effect on the studied risk.
In the scenario b1 = b2 = b3 = log(2), when Z2 was
Table 2 Mean of the predictive ability estimates (Est), mean of the standard error estimates
∧
SE and standard error of
the estimates (SE).
b1 = b2 = b3 = 0 b1 = b3 = log(2), b2 = log(1.5) b1=b2=b3=log(2)
Est
∧
SE SE % H0 rejected Est
∧
SE SE % H0 rejected Est
∧
SE SE % H0 rejected
Full Cohort
C1 0.518 0.033 0.012 0.727 0.032 0.015 0.733 0.029 0.014
C2 0.524 0.033 0.013 0.747 0.031 0.015 0.733 0.029 0.014
  0.006 0.010 0.009 3.7 0.020 0.007 0.007 91.6 0.049 0.010 0.010 100
NRI 0.007 0.017 0.019 4.8 0.071 0.030 0.033 52.5 0.167 0.034 0.035 99.9
IDI 2e
-4 2e
-4 3e
-4 6.0 0.014 0.003 0.005 99.9 0.048 0.006 0.009 99.9
MI1000
C1 0.518 0.033 0.012 0.724 0.032 0.016 0.733 0.029 0.014
C2 0.526 0.033 0.013 0.745 0.031 0.016 0.783 0.027 0.014
Δ 0.008 0.012 0.010 3.4 0.021 0.008 0.008 90.6 0.049 0.010 0.011 100
NRI 0.009 0.019 0.017 1.5 0.076 0.033 0.033 64.8 0.172 0.037 0.036 100
IDI 3e
-4 3e
-4 4e
-4 3.5 0.014 0.004 0.005 99.0 0.045 0.008 0.010 100
MI300
C1 0.518 0.033 0.012 0.724 0.032 0.016 0.733 0.029 0.014
C2 0.528 0.033 0.012 0.745 0.031 0.017 0.783 0.027 0.015
Δ 0.010 0.014 0.011 3.0 0.021 0.008 0.009 84.6 0.050 0.011 0.012 100
NRI 0.013 0.023 0.018 1.3 0.076 0.035 0.035 57.0 0.172 0.039 0.039 99.7
IDI 4e
-4 4e
-4 5e
-4 1.8 0.014 0.005 0.006 87.5 0.046 0.010 0.012 100
CC1000
C1 0.528 0.032 0.013 0.667 0.033 0.015 0.670 0.031 0.014
C2 0.534 0.033 0.015 0.709 0.032 0.022 0.737 0.029 0.014
Δ 0.006 0.010 0.010 4.7 0.043 0.011 0.017 100 0.067 0.012 0.012 100
NRI 0.017 0.031 0.033 6.7 0.147 0.039 0.043 96.7 0.261 0.041 0.043 100
IDI 0.002 0.001 0.003 15.2 0.058 0.009 0.014 100 0.114 0.011 0.017 100
CC300
C1 0.523 0.034 0.013 0.620 0.037 0.016 0.620 0.034 0.015
C2 0.529 0.034 0.015 0.647 0.036 0.016 0.668 0.032 0.015
Δ 0.006 0.010 0.009 3.6 0.027 0.011 0.011 83.3 0.048 0.013 0.013 99.8
NRI 0.019 0.039 0.043 6.2 0.154 0.043 0.050 94.4 0.257 0.046 0.051 99.9
IDI 0.002 0.001 0.003 13.9 0.040 0.008 0.014 99.8 0.078 0.010 0.017 100
Results from 1000 simulations
C1 Harrell’s C index of the proportional hazard model without the phase-2 variable
C2 Harrell’s C index of the proportional hazard model with the phase-2 variable
Δ, Harrell’s predictive value of the phase-2 variable, H0: Δ =0
NRI, Net reclassification index by adding the phase-2 variable, H0: NRI = 0 IDI, Integrated discrimination index by adding the phase-2 variable, H0: IDI = 0
Cohort, full cohort estimates; MI300, MI1000: multiple imputation estimates with subcohort sizes set, respectively, at 300 and 1,000; CC300, CC1000, case-cohort
estimates with subcohort sizes set, respectively, at 300 and 1,000
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Page 6 of 10uniformly distributed, MI and full cohort analysis still
provided similar estimates. However, when Z2 was log-
normally distributed, the MI estimate was slightly smal-
ler than the full cohort estimate -15%).
Mean of the predictive ability estimates (Est), mean of
the standard error estimates
∧
SE and standard error of
the estimates (SE), with a correctly specified normal
imputation model (Z2 normally distributed), and with
two misspecified normal imputation models (Z2 log-nor-
mally and uniformly distributed)
Application to the Three-City study
The mean fraction of missing information about the
effect of D-dimer was 4.9 and 3.7 per cent for CHD and
VaD risks, respectively. Table 4 gives the estimated
hazard ratios associated with D-dimer tertiles. The MI
and the weighted approaches yielded similar estimates
and precision. The CI of the hazard ratio associated
with the linear effect of a one-tertile difference were
respectively (0.94-1.38) versus (0.92-1.38) for CHD and
(1.13-2.53) versus (1.13-2.67) for VaD. For phase-1 vari-
ables, both estimators provided similar results, but MI
was always the more precise (data not shown).
Harrell’s C for the models including only phase-1 vari-
ables were above 0.69 for CHD risk and above 0.86 for
V a Dr i s k( T a b l e5 ) .H e n c e ,C H Da n dV a Dr i s k sw e r e
largely explained by standard risk factors, and the inclu-
sion of plasma D-dimer levels did not significantly
improve the predictive ability of the model, despite the
fact that elevated D-dimer levels significantly increased
the VaD risk. For CHD as for VaD, the index did not
significantly differ from 0.
Discussion
Use of a consistent estimator does not guarantee the
absence of any bias for finite sample. We only showed
Table 3 Predictive ability of the two models and of the phase-2 variable.
Full cohort Multiple imputation
Est
∧
SE SE % H0 rejected Est
∧
SE SE % H0 rejected
Z2 normally distributed
b1 = b2 = b3 =0
C1 0.518 0.033 0.012 0.518 0.033 0.012
C2 0.524 0.033 0.013 0.526 0.033 0.013
Δ 0.006 0.010 0.010 3.7 0.008 0.012 0.010 3.4
b1 = b2 = b3 = log(2)
C1 0.733 0.029 0.014 0.733 0.029 0.014
C2 0.783 0.027 0.013 0.783 0.027 0.014
Δ 0.049 0.010 0.010 100 0.049 0.010 0.011 100
Z2 normally distributed
b1 = b2 = b3 =0
C1 0.518 0.033 0.012 0.518 0.033 0.012
C2 0.524 0.033 0.013 0.520 0.031 0.016
Δ 0.006 0.010 0.009 5.5 0.002 0.013 0.012 4.2
b1 = b2 = b3 = log(2)
C1 0.784 0.013 0.006 0.784 0.013 0.006
C2 0.881 0.011 0.006 0.866 0.011 0.006
Δ 0.097 0.005 0.005 100 0.082 0.005 0.004 100
Z2 uniformly distributed
b1 = b2 = b3 =0
C1 0.532 0.055 0.019 0.532 0.055 0.019
C2 0.540 0.055 0.019 0.541 0.055 0.020
Δ 0.008 0.015 0.013 2.2 0.009 0.017 0.013 4.0
b1 = b2 = b3 = log(2)
C1 0.733 0.029 0.014 0.733 0.029 0.014
C2 0.781 0.027 0.012 0.785 0.027 0.012
Δ 0.048 0.009 0.009 100 0.052 0.010 0.010 100
Results of 1000 simulations
C1, Harrell’s C index of the proportional hazard model without the phase-2 variable
C2, Harrell’s C index of the proportional hazard model with the phase-2 variable
Δ, Harrell’s predictive value of the phase-2 variable, H0: Δ =0
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Page 7 of 10that MI analysis of case-cohort data provides unbiased
estimates of the log-hazard ratio when the imputation
model and the proportional hazard model are correctly
specified. The misspecification of the imputation model
can originate from an erroneous choice of the distribu-
tion, or from wrongly assuming that the estimator of
the imputation model is consistent and normal, or from
the omission of some important explanatory variable.
Imputations carried out using a misspecified distribution
in the imputation model can provide biased estimates of
hazard ratios, especially, if the specified distribution of
the phase-2 variable differs from the true one in terms
of symmetry (log-normal versus normal distribution).
The negative bias on a log hazard ratio of 0.69 was
noticeable but not large when a log-normal variable was
imputed according to a normal distribution (-0.09 or
-13%), but it is clearly a type of misspecification easily
identified with diagnostic tools [20]. One can then trans-
form the incomplete variable in order to obtain a sym-
metrical distribution, impute transformed values and
apply the inverse transformation to the imputed values.
Note that although a normal and a uniform distribution
are quite different, both are symmetrical and the
observed bias was quite smaller (only 5%). In the 3C
study of the relationship between VaD and D-dimer, we
observed slightly different estimates of the log hazard
ratio when comparing the third to the first tertile (2.77
versus 2.93, i.e. a relative difference of 8% between the
MI and the weighted estimates). This is probably
because of the qualitative imputation of D-dimer, and
thus, the use of a multinomial imputation model, which
implied estimation of parameters in separate strata
defined by D-dimer concentration tertiles, some of
which had a small number of events. Due to these small
numbers (only 51 VaD in total), asymptotic conditions
might not have been fulfilled in at least some strata, and
the estimated coefficients of the imputation model could
have been biased and notnormally distributed. We give
below some recommendations regarding the choice of
explanatory variables in the imputation model. Since the
potential bias of MI estimates can be detected by com-
paring them to weighted estimates, we suggest building
the proportional hazard model by using only the case-
cohort data and weighted estimators. MI can eventually
be used to reanalyze the data with the selected model to
improve the precision of the results, while verifying that
no bias was introduced.
In simulated data, for the phase-1 variables, the preci-
sion of MI and full cohort estimates was similar and
smaller than with the weighted estimator. For the
phase-2 variable, MI estimates were slightly more pre-
cise than weighted estimates. Globally, the mean
squared errors were smaller with MI than with the
weighted estimator, with one exception implying a nor-
mal imputation model for a log-normally distributed
phase-2 variable, an error which should easily be
avoided.
There is no standard method for estimating the pre-
dictive ability of a model in the framework of case-
cohort surveys. We showed that the naive application of
the C index to case-cohort surveys yielded an underesti-
mation of the predictive ability of the model that
depended on the subcohort size when the phase-2 vari-
able had an effect on the risk. Similarly, the naive esti-
mates of the predictive ability of an added phase-2
variable differed notably from the full cohort values
when the effect of the phase-2 variable was not null.
Harrell’s C index could theoretically be estimated with a
Table 4 Estimates of hazard ratios (HR) and 95%
confidence interval (CI) associated with D-dimer tertiles.
Multiple imputation
estimates
Weighted
estimates
HR (95% CI) HR (95% CI)
Risk of CHD and D-
Dimer
a
T1 1.00 (reference) 1.00 (reference)
T2 1.42 (0.99-2.04) 1.40 (0.97-2.04)
T3 1.32 (0.89-1.97) 1.30 (0.84-1.99)
Linear trend 1.14 (0.94-1.38) 1.13 (0.92-1.38)
Risk of VaD and D-
Dimer
b
T1 1.00 (reference) 1.00 (reference)
T2 1.57 (0.63-3.93) 1.60 (0.63-4.09)
T3 2.77 (1.17-6.57) 2.93 (1.22-7.06)
Linear trend 1.69 (1.13-2.53) 1.74 (1.13-2.67)
CHD, cardiovascular heart disease; T1, tertile 1; T2, tertile 2; T3, tertile 3; VaD,
vascular dementia
a Adjusted for age, center, sex, body mass index, hypertension,
hypercholesterolemia, diabetes, diabetes drugs, tobacco use
b Adjusted for age, center, sex, educational level, body mass index,
apolipoprotein ε4
Table 5 Predictive ability and 95% confidence interval
(CI) of D-Dimer tertiles on cardiovascular heart disease
(CHD) and vascular dementia (VaD) risks.
CHD VaD
Estimate 95% CI Estimate 95% CI
C1 0.693 (0.622-0.764) 0.865 (0.787-0.943)
C2 0.694 (0.621-0.767) 0.874 (0.798-0.950)
Δ 0.002 (-0.004-0.008) 0.009 (-0.011-0.029)
NRI 0.009 (-0.049-0.066) - -
IDI 0.001 (-0.001-0.003) 0.0004 (-0.0002-0.0010)
C1, Harrell’s C index of the proportional hazard model without the phase-2
variable
C2, Harrell’s C index of the proportional hazard model with the phase-2
variable
Δ, Harrell’s predictive ability of the phase-2 variable
NRI, net reclassification improvement by adding the phase-2 variable IDI,
integrated discrimination index by adding the phase-2 variable
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Page 8 of 10weighted approach, but this can be computationally dif-
ficult because it requires weighting each pair by the
pairwise sampling probabilities, i.e., using a square
matrix of size N’(N’-1), where N’ is the size of the case-
cohort sample. Computing the variance of this Horvitz-
Thompson estimator requires either weighting each
quadruplet by the quadruple-wise sampling probabilities,
i.e., working with a matrix of size N’(N’-1)(N’-2)(N’-3),
or bootstrapping the case-cohort data. By contrast, MI
easily allows estimation of the predictive ability of a
model or of an additional phase-2 variable and their var-
iances in the context of case-cohort data, only requiring
bootstrapping to estimate the variance of the predictive
ability of the phase-2 variable. MI provided estimates of
Harrell C, NRI and IDI indexes similar to those
obtained with the full cohort analysis. Note, however,
that the predictive abilities were always overestimated
because the same data were used to estimate the model
and its predictive ability.
Analysis of the Three-City case-cohort study was in
agreement with our previous work [10]. The weighted
and the MI approaches yielded similar estimates of the
hazard ratios and MI was slightly more precise, particu-
larly for phase-1 variables. The relative differences
between both estimates was always below 2% for the
hazard ratios related to CHD and D-dimer, but as early
discussed, they could be slightly higher (8%) for a hazard
ratio related to VaD and D-dimer. The precision was
similar for both analyses.
The imputation model must reflect the association
between the incomplete variable, the outcome and the
other explanatory variables. Therefore, variables
included in the proportional hazard model as well as the
stratification variables must be included in the imputa-
tion model. If a surrogate of the phase-2 variable is
available, it should also be included in the imputation
model. On the other hand, multiple imputation
approach can provide unbiased and more efficient esti-
mates than weighted analysis even when no strong pre-
dictor of the phase-2 variable is available [10]. The
inclusion of additional variables other than strongly pre-
dictive variables can lead to an increased inter-imputa-
tion variance. This prompted the use of different
imputation models for D-dimer levels in the CHD and
VaD analyses. However, we verified that adding the vari-
a b l e so n l yu s e di nt h eC H Da n a l y s i st ot h em o d e lu s e d
for VaD, did not modify the results observed in the for-
mer (data not shown).
The number of requested imputations depends on the
proportion of missing information which, in case-cohort
studies, is considerably smaller than the percentage of
incompletely observed subjects. Rubin showed that with as
much as 40 per cent information missing, M = 5 imputa-
tions provides an asymptotic relative efficiency was 0.97,
and, with 50 per cent missing information, M = 10 pro-
vides an asymptotic relative efficiency of 0.98. Thus, a
small number of imputations, 5-10, should suffice [21]. In
our analyses, we used 5 imputations to limit the computer
time of the simulations, a reasonable choice since the pro-
portion of missing information was always smaller than 30
per cent. However, a slightly larger number of imputations
(e.g. 10) could have been performed on the 3C study data
at a reasonable time cost; it would have provided a more
precise estimate of the between imputation variance and
of the percentage of missing information.
The VaD risk increased with D-dimer tertiles. How-
ever, D-dimer inclusion did not significantly improve
the predictive ability of the model for VaD risk. Compu-
tations of the C and IDI index yielded the same conclu-
sion. To our knowledge, no other results concerning the
predictive ability of D-dimer on the risk of VaD have
been published to date. The risk of CHD did not vary
with D-dimer, so, not surprisingly, the predictive ability
of this variable was negligible, regardless of the index
used. Wang et al. [22] and Tzoulaki [23] reported that
the use of 10 and 4 biomarkers respectively added only
moderately to the overall risk prediction based on con-
ventional cardiovascular risk factors.
Conclusions
MI is a simple alternative approach to weighted analysis
for analyzing case-cohort surveys, obtaining correct esti-
mates of the log hazard ratios and their standard errors,
improving precision for the phase-1 variable estimates,
and providing at least the same precision as weighted
estimators for phase-2 variable estimates. It allows an
easy evaluation of the predictive ability of the model
and, more generally, any tool proposed in the frame-
work of cohort studies can be applied to case-cohort
data using MI.
Abbreviations
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